JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
11 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
-Issues regarding Healthy Heroes, partnership with the VA on Suicide Prevention, integrated marketing, clinical trials and personalized medicine. -Issues related to VA medical device procurement issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| KELLY WATERS | — |
Medicare/Medicaid MMM
- Issues related to reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BARNARD | — |
Trade (domestic/foreign) TRD
-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Taxation/Internal Revenue Code TAX
- Issues related to miscellaneous tax bills. - Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 - A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Copyright/Patent/Trademark CPT
- Patent Trade Office reforms - H.R.1520-Purple Book Continuity Act of 2019, regarding all provisions - H.R.1503-Orange Book Transparency Act of 2019, regarding all provisions - H.R.1499-Protecting Consumer Access to Generic Drugs Act of 2019, regarding all provisions - S.649 -Biologic Patent Transparency Act, regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Budget/Appropriations BUD
-Issues related to FY2020 Appropriations, specifically the Special Olympics, The Global Fund, Food & Drug Administration, Commerce, Interior, and Environmental Protection Agency budgets.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| MICHAEL BARNARD | — |
| LEIF BRIERLEY | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| MEGHAN DRENAN STONE | — |
| KELLY WATERS | — |
Environment/Superfund ENV
- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions - H.R. 2588/S. 1371 - Oxybenzone and Octinoxate Impact Study Act of 2019, regarding all provisions - H.R. 2587/S. 1375 - Reef Safe Act of 2019, regarding all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Labor Issues/Antitrust/Workplace LBR
- Issues related to corporate governance - Issues related to diversity & Inclusion - HR 5, "Equality Act", regarding all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| LARRY CAMM New | — |
| KELLY WATERS | — |
Torts TOR
- Issues related to civil justice reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
Science/Technology SCI
- Issues related to data privacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
Health Issues HCR
- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the reputation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to the medical device tax repeal - Issues related to medical product communications - Issues related to medical product review - Issues related to talc safety - Issues related to drug pricing reform - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| MICHAEL BARNARD | — |
| LEIF BRIERLEY | — |
| ANNE BRUCE | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| MEGHAN DRENAN STONE | — |
| KELLY WATERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.